|
Current Events
|
SFHHA presents
1st Annual Healthcare Night and Mixer
Th., Aug. 3 | 7 pm
Hard Rock Stadium | Miami
~~~~~~~~
AAHAM Florida Sunshine Chapter presents
Health Insurance Institute
Wed., 8/16/17 - Fri., 8/18/17
Palm Beach Gardens
Register/Learn More
~~~~~~~~
SFMGMA and NAHSE Collaborative Education Event
Great Healthcare Leadership Wanted: Navigating Your Career
Thurs., Aug. 24, 5:30 - 8 pm
Miramar
Register/Learn More
____________
|
|
|
Publisher of
:
Week in Review,
Specialty Focus,
Updates in Pediatrics,
FHIweekly & Game Changers
Creator of:
The Healthcare Roundtable Series
INFORM | CONNECT | ENGAGE
|
|
Do You Know a Healthcare Game Changer?
|
|
|
|
The Campbell Foundation Funds Research to Study Ways to Reverse Premature Aging in People With HIV
|
Thanks to effective antiretroviral (ARV) therapy, more than half of those living with HIV/AIDS in the United States are 50 years or older. While it's good news that people are living longer, it comes with a price: Premature aging. This often results in numerous comorbidities that are not seen in those who are HIV negative until they are much older.
The Campbell Foundation, a Fort Lauderdale, FL based nonprofit that funds HIV and AIDS research, has awarded a $75,000 grant to Dr. Theodoros Kelesidis, an infectious disease specialist at David Geffen School of Medicine at UCLA. The grant will be used to study ways to use two powerful antioxidants designed to slow the progress of HIV associated with T-Cell dysfunction.
"Premature aging is a dire and pressing consequence of chronic HIV infection, so this grant is very timely," said The Campbell Foundation's Executive Director Ken Rapkin. "Research has found that the aging process speeds up by about five years on average for those with HIV."
Dr. Kelesidis and his team will use the grant to investigate whether a novel mitochondrial antioxidant (MitoQ), and another potent antioxidant (4F) can help to stop the progression of T-Cell dysfunction associated with aging.
|
Healthgrades Names West Boca Medical Center as a 5-Star Recipient for Labor & Delivery Care
|
West Boca Medical Center has achieved the prestigious 5-Star Rating for Labor & Delivery recognition from Healthgrades, a leading online resource for comprehensive information about physicians and hospitals. This 5-star rating indicates that the hospital's clinical outcomes are statistically significantly better than expected when treating the condition or performing the procedure being evaluated. West Boca Medical Center is now a Five Star Recipient for Vaginal Delivery for three years in a row, (2015-2017) and a Five Star Recipient for C-Section Delivery for three years in a row (2015-2017).
"People in our community have a choice as to where they will go for their optimal birthing experience and this recognition is confirmation that our hospital has proven to be one of the best in our area when it comes to labor and delivery services, said Mitch Feldman, CEO at West Boca Medical Center. "In addition to having the only level III NICU in south Palm Beach County, accolades such as this make us unique to our patients.
|
Miami Cancer Institute to Acquire ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
|
Miami Cancer Institute, part of Baptist Health South Florida, announced yesterday that it will acquire ViewRay's MRIdian Linac System, the world's first and only FDA-cleared MRI-guided radiation therapy system. The MRIdian system will be part of the healthcare organization's new Miami Cancer Institute, a multidisciplinary, destination cancer center and member of the Memorial Sloan Kettering Cancer Alliance. The MRIdian treatments are expected to be available for patient care in spring 2018.
Nearly two-thirds of all treated cancer patients in the United States will receive some form of radiation therapy during the course of their illness, according to estimates by the American Society for Radiation Oncology. The movement of tumors and internal organs makes precision radiation delivery a challenge, but through the use of MRI-guidance, clinicians are better able to aim radiation therapy directly at tumors while avoiding surrounding tissues.
|
|
|
